Would a be a good addition in my personal opinion. Few bits of positive news, currently undervalued and underpriced. Last month has shown parabolic rise in price.
Based on 2 Wall Street analysts offering 12 month price targets for TRACON Pharmaceuticals in the last 3 months. The average price target is $3.50 with a high forecast of $6.00 and a low forecast of $1.00. The average price target represents a 455.56% change from the last price of $0.63.